This once-hot cancer-detection company’s stock got cut in half after a failed trial
Grail’s stock was the Nasdaq’s biggest loser Friday, after a key trial of its Galleri early-detection cancer test failed to meet its primary endpoint. View…
Grail’s stock was the Nasdaq’s biggest loser Friday, after a key trial of its Galleri early-detection cancer test failed to meet its primary endpoint. View…
Also in Weekend Reads: Reactions to the Supreme Court ruling against Trump’s tariffs, AI and your taxes, and a deeper look into business-development companies. View…
The Supreme Court’s decision striking down most of President Donald Trump’s tariffs left at least one big question unanswered: What about refunds? View Source Robert…
Target, Nike and Hasbro stand to be big beneficiaries as the SCOTUS ruling could lower costs, analysts say, but stocks of retail giants like Walmart…
Subverting the conventional wisdom that the only stock exposure you need is in the broad indexes. View Source Brett Arends MarketWatch.com – Top Stories February…
View Source Most popular articles February 20, 2026 11:35 am
The Supreme Court decision just made ‘money talks’ with your partner a lot less stressful. View Source Brian Page MarketWatch.com – Top Stories February 20,…
The proposed ETFs are all tied to prediction markets related to U.S. elections. View Source Gordon Gottsegen MarketWatch.com – Top Stories February 20, 2026 11:15…
“My son is smart — he really is — but he was in love.” View Source Quentin Fottrell MarketWatch.com – Top Stories February 20, 2026…
Because of Blue Owl, concerns over private BDCs have spilled over to push down prices of publicly traded BDCs — many of which trade at…